Categories: Artificial IntelligenceDevelopmentHealthTechMachine LearningPlatform
Stately Bio is developing the next generation of life-saving regenerative medicines with the world's most advanced ML cell imaging platform.
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.05.2025 | Seed | $12M | - |
Mentions in press and media 2
| Date | Title | Description |
| 01.05.2025 | Stately Bio Raises $12M in Seed Funding | Stately Bio, a Palo Alto, CA based startup developing cell therapies using an ML-powered live-cell imaging platform, raised $12m in seed funding.
The round was led by AIX Ventures, with participation from Dimension Capital, Foothill Venture... |
| - | Stately Bio | “Stately Bio is developing the next generation of life-saving regenerative medicines with the world's most advanced ML cell imaging platform.” |
Reviews 0
